Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
AssigneePro Aparts-Investimentos E Consultoria Lda
InventorHajime Shibuya
Life of this patent
Estimating the term…
Abstract
The use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3), docosahexaenoic acid (DHA, C.sub.22:6 .omega.-3), or their pharmaceutically acceptable derivatives is described for the primary prevention of major cardiovascular events in subjects who have not undergone previous infarct episodes.
Claims16
A method of reducing the probability of an occurrence of a major cardiovascular event in a subject who has not undergone a previous infarct episode, comprising administering to the subject an effective amount of a pharmaceutical composition comprising ω-3 fatty acids comprising eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), a C1-C3 alkyl ester thereof, a pharmaceutically acceptable salt thereof, or mixtures thereof, in an amount of at least 25% by weight of total fatty acids.
Dependencies are inferred from the claim text.